Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

therapeutics   save search

Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
Published: 2023-02-08 (Just crawled : 18:00) - biospace.com/
DSGN A | $7.47 -6.16% 73K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

biopharma global conference therapeutics
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments
Published: 2023-02-08 (Crawled : 17:00) - biospace.com/
OVID | $2.47 -2.37% 18K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

therapeutics
Todays' Top-5
Hoth Therapeutics Announces Increased Positive Results of its Alzheimer's Therapeutic HT-ALZ
Published: 2023-02-08 (Crawled : 17:00) - biospace.com/
HOTH | $3.95 -8.14% 6.9M twitter stocktwits trandingview |
Health Technology
| | O: 11.33% H: 0.0% C: 0.0%

alzheimer's therapeutics positive results
ALERT: PLDT Inc. Investors with Substantial Losses Have Opportunity to Lead the PLDT Class Action Lawsuit - PHI
Published: 2023-02-08 (Crawled : 16:00) - prnewswire.com
PHI | $25.34 1.0% 23K twitter stocktwits trandingview |
Communications
| | O: -0.12% H: 0.0% C: 0.0%
FATE A | $6.56 -4.09% 900K twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%


BioXcel Therapeutics to Host BXCL701 Key Opinion Leader Day to Highlight Company’s Investigational, Oral Innate Immune Activator for Rare Form of Prostate Cancer
Published: 2023-02-08 (Crawled : 15:00) - biospace.com/
BTAI | $33.125 7.93% 540K twitter stocktwits trandingview |
Health Technology
| | O: 5.48% H: 0.0% C: 0.0%

bxcl701 day rare for therapeutics cancer
Silence Therapeutics to Present at SVB Securities Global Biopharma Conference
Published: 2023-02-08 (Crawled : 14:20) - biospace.com/
SLN | $12.9 -0.54% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.15% H: 0.0% C: 0.0%

biopharma global conference therapeutics
NeuroSense Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial
Published: 2023-02-08 (Crawled : 14:20) - prnewswire.com
NRSN | $1.72 12.42% 680K twitter stocktwits trandingview |
| Email alert Add to watchlist

enroll als trial approval germany
Bicycle Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
BCYC | $28.93 0.21% 100K twitter stocktwits trandingview |
Health Technology
| | O: 3.7% H: 0.0% C: 0.0%

biopharma global conference therapeutics bicycle
Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
FOLD M | $12.715 0.28% 600K twitter stocktwits trandingview |
Health Technology
| | O: -2.56% H: 0.0% C: 0.0%

biopharma global conference therapeutics
C4 Therapeutics to Present at Two Virtual February 2023 Conferences
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
CCCC M | $5.71 -9.51% 370K twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 0.0% C: 0.0%

therapeutics
Poseida Therapeutics to Host Third Annual Virtual R&D Day on February 22, 2023
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
PSTX F | $8.47 -2.98% 330K twitter stocktwits trandingview |
Health Technology
| | O: 5.03% H: 0.0% C: 0.0%

day therapeutics
CRISPR Therapeutics to Participate in Upcoming Investor Conferences - February 8, 2023
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
CRSP | $54.18 -2.67% 350K twitter stocktwits trandingview |
Health Technology
| | O: -1.59% H: 0.0% C: 0.0%

crispr therapeutics
Astria Therapeutics Initiates ALPHA-STAR Phase 1b/2 Clinical Trial of STAR-0215 in People with HAE
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
ATXS | $14.425 -7.06% 180K twitter stocktwits trandingview |
Manufacturing
| | O: 1.85% H: 0.0% C: 0.0%

star-0215 trial therapeutics
Palisade Bio Promotes Robert McRae to Chief Operating Officer
Published: 2023-02-08 (Crawled : 14:00) - globenewswire.com
VIRX | $1.96 36K twitter stocktwits trandingview |
Manufacturing
| | O: 5.32% H: 0.0% C: 0.0%


Seres Therapeutics Announces Initiation of Enrollment in SER-155 Phase 1b Study Cohort 2 in Individuals Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Published: 2023-02-08 (Crawled : 13:20) - biospace.com/
MCRB A | $5.395 -0.83% 940K twitter stocktwits trandingview |
Health Technology
| | O: -2.55% H: 0.0% C: 0.0%

ser-155 therapeutics study
Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss
Published: 2023-02-08 (Crawled : 13:20) - biospace.com/
LCTX | $1.415 -1.74% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%

treatment for program update
Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas
Published: 2023-02-08 (Crawled : 13:00) - biospace.com/
IPSC A | $4.695 -1.37% 45K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 3.34% H: 0.0% C: 0.0%

cnty-101 lymphomas cd19 trial therapeutics positive
Karyopharm to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
KPTI | $3.425 -2.7% 530K twitter stocktwits trandingview |
Health Technology
| | O: 4.18% H: 0.0% C: 0.0%

report year financial results
Orchard Therapeutics Announces Comprehensive Presence at 19th Annual WORLDSymposium
Published: 2023-02-08 (Crawled : 12:20) - globenewswire.com
ORTX | $0.56 4.48% 130K twitter stocktwits trandingview |
Health Technology
| | O: 6.67% H: 0.0% C: 0.0%

therapeutics
Global Companion Diagnostic Markets Report 2023: Companion Diagnostics are Changing Cancer Management and are Poised to Move into New Therapeutic Eras
Published: 2023-02-08 (Crawled : 12:00) - prnewswire.com
TMO | $582.8 -0.06% 460K twitter stocktwits trandingview |
Health Technology
| | O: 1.27% H: 0.0% C: 0.0%
NVTA | $2.4 -3.23% 5.5M twitter stocktwits trandingview |
Health Services
| | O: -1.79% H: 0.0% C: 0.0%
BDX S | $250.35 -1.12% 370K twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 0.0% C: 0.0%
ABT | $110.32 -1.49% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.98% H: 0.0% C: 0.0%

management global report diagnostic diagnostics cancer
Gainers vs Losers
54% 46%

Top 10 Gainers
DGLY | $5.43 1722.15% 160K twitter stocktwits trandingview |
Electronic Technology

CELZ | $1.115 115.54% 120M twitter stocktwits trandingview |

AVRO | $1.78 104.01% 11M twitter stocktwits trandingview |
Health Technology

GFAI | $0.4765 39.53% 61M twitter stocktwits trandingview |

WETG | $0.551 34.39% 13M twitter stocktwits trandingview |

KPRX | $6.11 34.29% 15M twitter stocktwits trandingview |
Manufacturing

PRFX | $0.65 30.0% 13M twitter stocktwits trandingview |
Health Technology

BBLG | $0.3799 20.76% 740K twitter stocktwits trandingview |
n/a

NEWR A | $77.25 19.62% 2.7M twitter stocktwits trandingview |
Technology Services

THCH | $4.99 18.81% 560K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.